BioProcess International

That's a wrap on our BioProcess International Conference & Exhibition 2024 in Boston! Aside from our enhanced onsite features including coffee baristas, daily live music, wine & cheese, lobster rolls, masseuse, manicurist, comfort seating, work pods, and charging ports in all session rooms, this year's event featured: ✓ 3200+ bioprocessing professionals from 36 countries ✓ All top 20 largest biopharma companies ✓ 100+ startups ✓ 340+ industry leading speakers across 9 tracks ✓ 220+ exhibitors supporting the entire bioprocessing spectrum ✓ Offsite networking party at Museum of Science Check out the latest highlights from this year's event! #biotechweekboston #BPIevent #CellGeneEvent #bioprocessing

Please join us for a #BPIAskTheExpert on "Introduction to Lonza CHO Media Portfolio: Harnessing Simplicity with the TheraPRO® CHO Media System." The growing field of #antibody #therapeutics is revolutionizing #healthcare by offering more precise treatments for various diseases. This advancement demands that #pharmaceutical companies efficiently produce high-quality proteins in large volumes. In this webinar, Sanjay Kumar, PhD will discuss Lonza’s CHO media portfolio, with a focus on the TheraPRO® GS CHO media system, highlighting key attributes and sharing compelling data generated with this system. Date: Thurs., October 31st. Time: 11 AM ET. Featuring: Sanjay Kumar, PhD, Head of Technical Excellence, Media Solutions, Lonza Bioscience Media Solutions. Register Now: https://lnkd.in/gACTW4AG

Be sure to check out our latest October 2024 issue of BioProcess International on downstream processing - available in print and digital! This issue features fascinating articles from talented professionals. Read on for a preview of the articles linked below: From the Editor: October 2024 by Cheryl Scott. The Crucial Role of Artificial Intelligence in Enhancing Clinical Outcomes by Ofer Sharon. Overcoming Scalability Barriers To Advance Cell Therapies in Development: CDMOs Can Be the Key to Success by Andy Lewin & Lior Raviv. Next-Generation Laboratory Moves: Strategies To Maximize Your Laboratory-Relocation Plan by Jasmina Xie. Influence of Air-Diffusion Value Shifts on Virus-Clearance Values: Safety Risk Assessment for Virus-Filter Integrity Testing in Multiround Housings HYEJEE JANG, Lalit Saxena, Seonmi Kim, Jihyun Lee, & Yonghwan Jin. Safeguarding Bioproduction Modalities: Comprehensive Testing Strategies Require Reliable Analytical Processes and Reference Materials by Leka Papazisi & Fang Tian. Lessons in Bioreactor Scale-Up, Part 4: Physiochemical Factors Affecting Oxygen Transfer and the Volumetric Mass-Transfer Coefficient in Stirred Tanks by Muhammad Arshad Chaudhry. Single-Use Devices for Alternating Tangential-Flow Filtration: Highly Efficient Perfusion Processes Over 50 Days (Webcast Recap) by Jan Ott. Enabling CDMOs To Focus on Their Core Priorities: Outsourcing Supply-Chain and Buffer-Preparation Activities by César Mauras. Beyond ELISA: Is Mass Spectrometry the Future of Impurity Analysis? by Thomas Kofoed, Margarita Sabater, Bryant McLaughlin, Søren Skov Jensen. Advanced Characterization of HCP Polyclonal Antibodies: Combining Antibody Affinity Extraction and Mass Spectrometry by Alla Zilberman, Jared Isaac, PhD MBA, & Eric Bishop. Fighting Neurodegenerative Diseases: The Need for Combination Biologics by Howard Berman, PhD. #downstreamprocessing #artificialintelligence #celltherapies #supplychain Follow the link below to read the full issue: https://lnkd.in/g4KQh3Xf

Please join us for a #BPIAskTheExpert on "Introducing Super Refined™ Poloxamer 188: Optimized for Mammalian Cell Culture with Exceptional Batch-to-Batch Consistency." Poloxamer 188 is a surfactant with a longstanding history of use in #pharmaceutical drugs, spanning dosage routes from oral to topical and parenteral administration. In the #biomanufacturing space, it finds application not only as a surfactant for parenteral biological formulations, but also in #cellculture as a shear stress protectant. Join this #webinar to understand exceptional performance in cell viability performance against competitor materials in both #CHO and #HEK suspension lines, analyze data highlighting batch-to-batch consistency in performance along with supporting #analytical data on the poloxamer compositional and impurity profile. Date: Tues., October 29th. Time: 11 AM ET. Featuring: James Humphrey, Research and Technology Specialist, Garima Sinha Lead Applications Scientist, Jessica Santa Maria, Technical Marketing Lead, Croda Pharma Register Now: https://lnkd.in/giQhCPCP

Please join us tomorrow for a #BPIAskTheExpert on "What if Your Supply Chain forSingle-Use Equipment Was Robust?" The #pandemic should have taught us that dual or multi-sourcing helps to strengthen #supplychains. But did you know that the implications for manufacturers and #CDMOs are even greater? Join this #webinar to learn more about the possibilities of using vendor-independent components for your #biopharmaceutical fluid path. Date: Thurs., October 24th. Time: 11 AM ET. Featuring: David Seifert, Head of Sales Application Engineering Sterile Consumables & Khalil Essani, Product Line Manager, Sterile Consumables, Single Use Support. Register Now: https://lnkd.in/g8YR6T-R

Day 1 of the Bioprocess International Asia Main Conference has officially started! 🥳 Our exceptional chairperson, Daisuke Kajihara, opened the day by introducing our keynote speaker, Takashi Kaminagayoshi from Takeda: 💡 Advanced Biomanufacturing Facilities - A Case Study 💡 We've also heard from Jack Wong and Christiane Hartmann in this morning's first session! Throughout the day, we'll gain valuable insights from a lineup of experts including Niki Wong, Sanjay Nilapwar, Wei Huang, Minh Tran, Jonggu (Kevin) Kim, Changlin Dou, Christoph Herwig, Haruki Takeuchi, Yasuhiro Takagi, Zach Pang,🌞 Thanks to our sponsors and exhibitors for supporting the event! #BPIAsia #CGT #kyoto #japan #biotech #biopharma Informa Connect Informa Connect Life Sciences BioProcess International

We are excited to share some insights on the future of rare disease research and how investment can drive innovation! 🌟 Catriona Crombie, Head of Rare Diseases at LifeArc, spoke to us on how rare diseases present unique challenges, but through collaboration, improved infrastructure, and smarter clinical trial designs, we can accelerate treatments and transform patient outcomes. LifeArc are investing £40 million in new Translational Centres to bridge gaps between academia, patients, and researchers, paving the way for faster and more impactful developments. Catriona will be speaking at Cell & Gene Therapy International Europe this December in Dublin! Find out more here: https://lnkd.in/eEy4ryR2 #RareDiseases #Innovation #CellAndGeneTherapy

Please join us for a #BPIAskTheExpert on "Enhancing Efficiency and Quality in Biopharmaceutical Manufacturing: The Strategic Value of Pre-Packed Chromatography Columns in Lean Manufacturing." Pre-packed chromatography columns have emerged as a valuable tool in process development, clinical manufacturing, and commercial production, offering significant advantages over self-packed columns. The adoption of pre-packed columns aligns with lean manufacturing best practices, which emphasize the reduction of non-value-adding activities. This study evaluates the benefits of using pre-packed columns in biopharmaceutical production. Date: Tues., October 15th. Time: 11 AM ET. Featuring: Adam Nelson, Chromatography Product Manager, Repligen Corporation. Register Now: https://lnkd.in/gWYW5hiV

We caught up with our Poster Winner Hunter Reese, Scientist II at Asklepios BioPharmaceutical, Inc. (AskBio) at BioProcess International! Hunter touches on some of the innovative research happening at AskBio and highlights the new advancements in the field of bioprocessing and gene therapy. Find out more below! #BioProcessInternational #CellandGeneTherapy

Please join us for a #BPIAskTheExpert on "Decoding AAV Manufacturing: Navigating Critical Quality Attributes and their Analytics." Gene therapy based therapeutics offer revolutionary ways of treating and curing genetic disorders. CMC plays a crucial part, however it is faced with complex manufacturing processes and the intrinsic complexity of the genetic therapeutics themselves. In this webinar, learn about key pre-quality attributes in AAV manufacturing and the cognate landscape of technologies analyzing them. There is a high need for more sophisticated methods for improving and deepening the understanding of the process and product. Date: Thurs., October 10th. Time: 11 AM ET. Featuring: Roland Pach, PhD, Global Analytical Expert, CMC, CGT, & Alternative Formats, Roche. Register Now: https://lnkd.in/gkcszM2M